UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.118

Sortiert nach

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure

Emerging infectious diseases, 2009-07, Vol.15 (7), p.1068-1076

2009

Link zum Volltext

Verfügbarkeit prüfen

Cryptic Species and Azole Resistance in the Aspergillus niger Complex

Antimicrobial Agents and Chemotherapy, 2011-10, Vol.55 (10), p.4802-4809

2011

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Susceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5778-5780

2013

Link zum Volltext

Verfügbarkeit prüfen

Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5426-5431

2013

Link zum Volltext

Verfügbarkeit prüfen

Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring

Clinical infectious diseases, 2009-09, Vol.49 (6), p.928-930

2009

Link zum Volltext

Verfügbarkeit prüfen

Implementing post-discharge care following acute kidney injury in England: a single-centre qualitative evaluation

BMJ open, 2020-08, Vol.10 (8), p.e036077-e036077

2020

Link zum Volltext

Verfügbarkeit prüfen

Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms in cyp51A, Upregulation of cyp51A, and Integration and Activation of Transposon Atf1 in the cyp51A Promoter

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5113-5121

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Fluconazole for Cryptococcal Meningoencephalitis: Implications for Antifungal Therapy and In Vitro Susceptibility Breakpoints

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2793-2800

2013

Link zum Volltext

Verfügbarkeit prüfen

Development of Novel PCR Assays To Detect Azole Resistance-Mediating Mutations of the Aspergillus fumigatus cyp51A Gene in Primary Clinical Samples from Neutropenic Patients

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3905-3910

2012

Link zum Volltext

Verfügbarkeit prüfen

Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins

Antimicrobial Agents and Chemotherapy, 2008-10, Vol.52 (10), p.3504-3511

2008

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Antifungal Drug Resistance

Cold Spring Harbor perspectives in medicine, 2015-07, Vol.5 (7), p.a019752-a019752

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy, 2010-08, Vol.54 (8), p.3432-3441

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Echinocandins against Candida glabrata: Requirement for Dosage Escalation To Achieve Maximal Antifungal Activity in Neutropenic Hosts

Antimicrobial Agents and Chemotherapy, 2011-10, Vol.55 (10), p.4880-4887

2011

Link zum Volltext

Verfügbarkeit prüfen

Combination of Voriconazole and Anidulafungin for Treatment of Triazole-Resistant Aspergillus fumigatus in an In Vitro Model of Invasive Pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy, 2012-10, Vol.56 (10), p.5180-5185

2012

Link zum Volltext

Verfügbarkeit prüfen

Adverse Reactions to Voriconazole

Clinical infectious diseases, 2004-10, Vol.39 (8), p.1241-1244

2004

Link zum Volltext

Verfügbarkeit prüfen

Post-discharge care following acute kidney injury: quality improvement in primary care

BMJ open quality, 2020-12, Vol.9 (4), p.e000891

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Itraconazole against Aspergillus fumigatus in an In Vitro Model of the Human Alveolus: Perspectives on the Treatment of Triazole-Resistant Infection and Utility of Airway Administration

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4146-4153

2012

Link zum Volltext

Verfügbarkeit prüfen

'Real-world' priority setting for service improvement in English primary care: a decentred approach

Public management review, 2023, Vol.25 (1), p.150-174

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days

mBio, 2014-01, Vol.5 (1), p.e00725

2014

Link zum Volltext

Verfügbarkeit prüfen

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

Journal of antimicrobial chemotherapy, 2010-10, Vol.65 (10), p.2116-2118

2010

Link zum Volltext

Verfügbarkeit prüfen

Azole-resistance in Aspergillus : Proposed nomenclature and breakpoints

Drug resistance updates, 2009-12, Vol.12 (6), p.141-147

2009

Link zum Volltext

Verfügbarkeit prüfen

Understanding the implementation of ‘sick day guidance’ to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation

BMJ open, 2017-11, Vol.7 (11), p.e017241-e017241

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy

The Journal of infectious diseases, 2011-05, Vol.203 (9), p.1324-1332

2011

Link zum Volltext

Verfügbarkeit prüfen

Multi-azole resistance in Aspergillus fumigatus

International journal of antimicrobial agents, 2006-11, Vol.28 (5), p.450-453

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised Patients

The Journal of infectious diseases, 2013-07, Vol.208 (2), p.351-361

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.931)
Mit Volltextzugriff
(1.818)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.112)
Japanisch
(313)
Französisch
(2)
Spanisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(88)
The New England Journal Of Medicine
(40)
Alzheimer's & Dementia
(26)
Clinical Cancer Research
(25)
Cancer
(24)
Plos One
(21)
Cancer Research
(19)
Circulation
(19)
Nature Communications
(19)
Clinical Infectious Diseases
(18)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure

Cryptic Species and Azole Resistance in the Aspergillus niger Complex

In Vitro Susceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole

Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method

Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring

Implementing post-discharge care following acute kidney injury in England: a single-centre qualitative evaluation

Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms in cyp51A, Upregulation of cyp51A, and Integration and Activation of Transposon Atf1 in the cyp51A Promoter

Pharmacokinetics and Pharmacodynamics of Fluconazole for Cryptococcal Meningoencephalitis: Implications for Antifungal Therapy and In Vitro Susceptibility Breakpoints

Development of Novel PCR Assays To Detect Azole Resistance-Mediating Mutations of the Aspergillus fumigatus cyp51A Gene in Primary Clinical Samples from Neutropenic Patients

Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins

Mechanisms of Antifungal Drug Resistance

Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis

Pharmacodynamics of Echinocandins against Candida glabrata: Requirement for Dosage Escalation To Achieve Maximal Antifungal Activity in Neutropenic Hosts

Combination of Voriconazole and Anidulafungin for Treatment of Triazole-Resistant Aspergillus fumigatus in an In Vitro Model of Invasive Pulmonary Aspergillosis

Adverse Reactions to Voriconazole

Post-discharge care following acute kidney injury: quality improvement in primary care

Pharmacodynamics of Itraconazole against Aspergillus fumigatus in an In Vitro Model of the Human Alveolus: Perspectives on the Treatment of Triazole-Resistant Infection and Utility of Airway Administration

'Real-world' priority setting for service improvement in English primary care: a decentred approach

Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

Azole-resistance in Aspergillus : Proposed nomenclature and breakpoints

Understanding the implementation of ‘sick day guidance’ to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation

Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy

Multi-azole resistance in Aspergillus fumigatus

Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised Patients

Suchergebnisse filtern